statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	338
VN - Vietnam	168
IT - Italia	166
SG - Singapore	139
CN - Cina	100
HK - Hong Kong	64
NL - Olanda	40
BD - Bangladesh	30
IE - Irlanda	19
KR - Corea	17
FR - Francia	16
BR - Brasile	15
DE - Germania	14
AT - Austria	13
IN - India	11
CH - Svizzera	10
JP - Giappone	9
SE - Svezia	9
PH - Filippine	8
TH - Thailandia	8
ZA - Sudafrica	8
GB - Regno Unito	7
CA - Canada	6
FI - Finlandia	6
ID - Indonesia	6
MX - Messico	6
PK - Pakistan	5
TG - Togo	5
TR - Turchia	5
CI - Costa d'Avorio	4
RU - Federazione Russa	4
TW - Taiwan	4
IQ - Iraq	3
PL - Polonia	3
BE - Belgio	2
CL - Cile	2
CR - Costa Rica	2
EC - Ecuador	2
NG - Nigeria	2
PT - Portogallo	2
UA - Ucraina	2
VE - Venezuela	2
AL - Albania	1
AR - Argentina	1
BG - Bulgaria	1
CM - Camerun	1
CO - Colombia	1
CY - Cipro	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
ET - Etiopia	1
HN - Honduras	1
IL - Israele	1
IS - Islanda	1
LU - Lussemburgo	1
PY - Paraguay	1
SC - Seychelles	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
Totale	1.302

Nome	#
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs	235
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma	235
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis	160
Outcome of hepatic resection for HCC in ideal and non-ideal candidates	156
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab	105
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors	101
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care	89
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study	86
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma	83
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab	51
Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic Review	35
Primary biliary cholangitis: current insights and novel therapies	9
Totale	1.345

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	42	0	0	0	0	0	0	0	10	1	7	21	3
2022/2023	66	2	7	2	2	7	3	16	2	10	1	7	7
2023/2024	35	1	3	1	3	3	4	2	11	2	2	0	3
2024/2025	170	7	10	13	9	7	9	27	6	7	33	16	26
2025/2026	1.009	58	42	58	62	71	36	158	66	233	100	44	81
2026/2027	23	23	0	0	0	0	0	0	0	0	0	0	0
Totale													1.345

CRIS Current Research Information System